The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase-Reference-Cited by-同舟云学术

The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase

Published:2022-02 Issue:2 Volume:298 Page:101531
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Heppler Lisa N.,Attarha Sanaz,Persaud Rosanne,Brown Jennifer I.,Wang Peng^ORCID,Petrova Boryana,Tošić Isidora,Burton Foster B.,Flamand Yael,Walker Sarah R.,Yeh Jennifer E.,Zubarev Roman A.,Gaetani Massimiliano,Kanarek Naama,Page Brent D.G.^ORCID,Frank David A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference45 articles.

1. Therapeutic modulators of STAT signalling for human diseases;Miklossy;Nat. Rev. Drug Discov.,2013

2. STAT3 inhibitors for cancer therapy: Have all roads been explored?;Fagard;JAKSTAT,2013

3. STAT inhibitors for cancer therapy;Furqan;J. Hematol. Oncol.,2013

4. Strategies and approaches of targeting STAT3 for cancer treatment;Furtek;ACS Chem. Biol.,2016

5. Do STAT3 inhibitors have potential in the future for cancer therapy?;Wong;Expert Opin. Investig. Drugs,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens;European Journal of Medicinal Chemistry;2024-01

2. DORSSAA: Drug-target interactOmics Resource based on Stability/Solubility Alteration Assay;2023-12-30

3. Pyrimidine salvage in Toxoplasma gondii as a target for new treatment;Frontiers in Cellular and Infection Microbiology;2023-12-15

4. Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia;Redox Biology;2023-11

5. Pyrimidine salvage inToxoplasma gondiias a target for new treatment;2023-11-01